Goldman Sachs Adds 4 Companies to US Conviction List With Huge Double-Digit Upside Potential

Goldman Sachs added four stocks to its June Conviction List, each with double-digit upside to price targets: Block ($95, +25%), Casella Waste Systems ($120, +46%), TPG ($61, +43%), and Tyson Foods ($81, +33%). The article highlights constructive analyst views on earnings growth, margin expansion, and business execution, with TPG also offering a 5.31% dividend and Tyson a 3.55% dividend. This is a positive analyst-sentiment piece rather than a company-specific catalyst, so the likely market impact is modest.

Analysis

The common factor across the additions is not “quality” so much as self-help with visible operating leverage. That matters because the market is still paying up for secular growth while discounting names where margin inflection is more execution-driven than narrative-driven; this creates a relative-value pocket in businesses with pricing power, recurring revenue, or contract-like economics. The cleaner expression is that the list is tilting toward cash-flow conversion stories where consensus is still underestimating the slope of the margin recovery.

TPG is the most interesting second-order beneficiary. If public market volatility keeps suppressing fundraising for weaker peers, capital is likely to concentrate further in scaled platforms with diversified fee streams, which should widen the gap between incumbents and sub-scale alternatives. The key risk is that management fee growth can look excellent on paper yet fail to translate into durable FRE expansion if incentive fees and realizations remain muted for another few quarters.

CWST and TSN are both more cyclical than the headlines suggest, but in opposite ways: CWST has a quasi-inflation-linked earnings profile that should hold up if pricing discipline remains intact, while TSN is effectively a beneficiary of normalization in protein spreads and better execution. The contrarian concern on TSN is that the market may be extrapolating a clean margin path too aggressively; protein businesses often look best right before input volatility or customer pushback compresses the next leg of gains. For Block, the risk/reward is still tied to adoption efficiency: if product initiatives do not improve active user monetization by mid-year, the market can quickly re-rate the story back to “optional exposure” rather than durable platform compounding.

Key Decisions for Investors

• Long TPG versus a basket of weaker-listed alt managers for 3-6 months; the setup is best if fundraising data stabilizes, with upside from multiple expansion and FRE growth. Risk: a weak private-markets tape that delays fee realization.
• Buy CWST on pullbacks as a 6-12 month compounder; the thesis is that pricing discipline and SG&A leverage can keep estimates drifting higher. Risk/reward is favorable because downside is protected by recurring local-monopoly economics.
• Use TSN as a tactical long only if commodity inputs remain orderly for the next quarter; target a 2:1 reward/risk into the dividend with a tighter stop if protein spreads roll over. Best entry is after any post-earnings digestion rather than preprint chasing.
• For XYZ, consider a call spread rather than stock ahead of the next operating update; the market is paying for execution, not optionality, so defined-risk upside is preferable. Risk: monetization and margin improvements need to show up faster than sentiment expects.
• If you want a relative-value expression, long CWST / short a lower-quality waste peer or long TPG / short a sub-scale alt manager can capture the theme without overpaying for beta.